Vemurafenib oral bioavailability: an insoluble problem

J Clin Pharmacol. 2014 Apr;54(4):375-7. doi: 10.1002/jcph.277.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents / pharmacokinetics*
  • Dietary Fats / pharmacokinetics*
  • Female
  • Food-Drug Interactions*
  • Humans
  • Indoles / pharmacokinetics*
  • Male
  • Melanoma / metabolism*
  • Protein Kinase Inhibitors / pharmacokinetics*
  • Sulfonamides / pharmacokinetics*
  • Vemurafenib

Substances

  • Antineoplastic Agents
  • Dietary Fats
  • Indoles
  • Protein Kinase Inhibitors
  • Sulfonamides
  • Vemurafenib